Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SLP
Strong BuyPremium GrowerSimulations Plus, Inc. · Healthcare · United States · $372M · Avg Vol: $3M/d
COMPANY DESCRIPTION
Simulations Plus, Inc. is a premier developer of biosimulation software and consulting services used in pharmaceutical research and drug development. The company's proprietary software, including GastroPlus, is widely adopted by global pharmaceutical firms and regulatory agencies like the FDA, creating high switching costs. It operates as a highly profitable, niche market leader in the computer-aided drug discovery sector.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53.9M | 59.6M | 70.0M | 79.2M | 13.7% | 82.1M | 81.9M | 86.3M | 4.4% |
| EPS | 0.62 | 0.50 | 0.50 | -3.22 | -10.2% | 0.40 | — | — | — |
| Shares | 20.3M | 19.9M | 20.1M | 20.1M | -0.6% | 20.2M | — | — | — |
| Debt | 1.4M | 1.2M | 1.0M | 0.6M | -24.0% | 0.5M | — | — | — |
| Equity | 178.2M | 170.0M | 182.4M | 124.8M | -11.2% | — | — | — | — |
| Op CF | 17.9M | 21.9M | 13.3M | 18.1M | 0.4% | 24.9M | — | — | — |
| Inv CF | 4.3M | 7.4M | -54.0M | 3.6M | — | — | — | — | — |
| Fin CF | -7.6M | -23.3M | -6.6M | -1.1M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SLP are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SLP | Simulations Plus, Inc.(you) | $372M | 83 | Strong Buy |
| NRC | NRC Health | $483M | 73 | Buy |
| SPOK | Spok Holdings, Inc. | $223M | 90 | Strong Buy |
| HSTM | HealthStream, Inc. | $859M | 87 | Strong Buy |
| AMWL | American Well Corporation | $203M | 75 | Buy |
| OPRX | OptimizeRx Corporation | $150M | 77 | Buy |
| WEAV | Weave Communications, Inc. | $583M | 64 | Hold |
| CTEV | Claritev Corporation | $668M | 66 | Buy |
| GDRX | GoodRx Holdings, Inc. | $1.2B | 77 | Buy |
| CCLD | CareCloud, Inc. | $106M | 77 | Buy |
Peer medians: ROE -30.8% · P/E 26.9x · Gross margin 58.1%